<?xml version="1.0" encoding="UTF-8"?>
<p>The antiviral activity of curcumin has been proven against many enveloped viruses, since this compound is able to modify the lipid bilayer and influences the function of the membrane protein [
 <xref rid="B133-biomolecules-11-00011" ref-type="bibr">133</xref>]. The curcumin antiviral effect was confirmed for HBV inhibition of mRNA in HuS-E/2 (50 µM: more than 40%) [
 <xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>]; for coxsackie virus (CVB3) in HeLa cells (MOI of 10; 30 µM) [
 <xref rid="B134-biomolecules-11-00011" ref-type="bibr">134</xref>] and JEV in Neuro2a cells (MOI of 5; 5 and 10 μM) [
 <xref rid="B135-biomolecules-11-00011" ref-type="bibr">135</xref>], acting as a host-target antiviral agent for both of these viruses by modulating ubiquitin–proteasome system; HSV-1 in pretreated VERO cells (MOI of 1; 10 μM) [
 <xref rid="B136-biomolecules-11-00011" ref-type="bibr">136</xref>]; HIV by different mechanisms [
 <xref rid="B137-biomolecules-11-00011" ref-type="bibr">137</xref>]; HCV entry in Huh-7.5 cells and primary human hepatocytes (IC
 <sub>50</sub> 8.46 ± 1.27 mM in Huh-7.5 and 12.5 µM in PHH) [
 <xref rid="B138-biomolecules-11-00011" ref-type="bibr">138</xref>]; and arboviruses like ZIKV and CHIKV in pretreated HeLa cells, inhibiting both infectious particle and viral-RNA (MOI of 0.1; IC
 <sub>50</sub>: 1.90 and 3.89 μM, respectively) [
 <xref rid="B139-biomolecules-11-00011" ref-type="bibr">139</xref>].
</p>
